In this Innovation Spotlight, Dan Levangie, president and chief executive officer of CereVasc, discusses a new treatment strategy for NPH using an endovascularly implantable CSF shunt that minimizes ...
BOSTON, Feb. 25, 2025 /PRNewswire/ -- CereVasc, Inc., a clinical-stage medical device company developing novel treatments for neurological diseases, announced today that the first patient has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results